Bristol myers squibb highlights progress of cell therapy portfolio at ash 2024 with long-term survival data and results from expanding pipeline

Princeton, n.j.--(business wire)---- $bmy #ash--bristol myers squibb highlights progress of cell therapy portfolio at ash 2024 with long-term survival data and results from expanding pipeline.
ASH Ratings Summary
ASH Quant Ranking